CHARLES SCHWAB INVESTMENT MANAGEMENT INC - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 64 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.60 and the average weighting 0.0%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$47,747
+289.6%
37,5960.0%0.00%
Q2 2023$12,256
-24.2%
37,5960.0%0.00%
Q1 2023$16,166
-18.9%
37,5960.0%0.00%
Q4 2022$19,926
-28.8%
37,5960.0%0.00%
Q3 2022$28,000
-34.9%
37,5960.0%0.00%
Q2 2022$43,000
-18.9%
37,596
+107.8%
0.00%
Q4 2021$53,000
-31.2%
18,0930.0%0.00%
Q3 2021$77,000
-19.8%
18,0930.0%0.00%
Q2 2021$96,000
-56.4%
18,093
-68.4%
0.00%
Q1 2020$220,000
-36.6%
57,3330.0%0.00%
Q4 2019$347,000
-20.0%
57,3330.0%0.00%
Q3 2019$434,000
-39.2%
57,333
+8.8%
0.00%
Q2 2019$714,000
+327.5%
52,688
+174.4%
0.00%
Q1 2018$167,000
-30.7%
19,2000.0%0.00%
Q4 2017$241,000
+49.7%
19,2000.0%0.00%
Q3 2017$161,000
-50.6%
19,2000.0%0.00%
Q2 2017$326,00019,2000.00%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
ETF MANAGERS GROUP, LLC 3,662,342$7,874,0000.16%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 213,469$438,0000.07%
GSA CAPITAL PARTNERS LLP 150,914$309,0000.04%
Bernardo Wealth Planning LLC 30,469$62,0000.03%
Penserra Capital Management LLC 351,154$719,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 175,900$361,0000.01%
Founders Capital Management 3,000$9,0000.01%
King Wealth Management Group 16,000$33,0000.01%
Aquatic Capital Management LLC 1,900$4,0000.01%
Newbridge Financial Services Group, Inc. 6,075$12,0000.01%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders